Skip to main content
Carna Biosciences, Inc. logo

Carna Biosciences, Inc. — Investor Relations & Filings

Ticker · 4572 ISIN · JP3220550002 T Manufacturing
Filings indexed 77 across all filing types
Latest filing 2016-03-25 Annual Report
Country JP Japan
Listing T 4572

About Carna Biosciences, Inc.

https://www.carnabio.com/

Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.

Recent filings

Filing Released Lang Actions
有価証券報告書-第13期(2015/01/01-2015/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, business indicators, and management information for the fiscal year ending December 31, 2015. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2015
2016-03-25 Japanese
四半期報告書-第13期第3四半期(2015/07/01-2015/09/30)
Interim / Quarterly Report
2015-11-09 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.